Financial data tables

Elevance Health (ELV) figures from its financial statements (company filings via Financial Modeling Prep), in US dollars; non-US reporters are converted to US dollars. Periods carry the company's own fiscal quarter and year, as its filings name them, with the date each period ended. Source filings are on the Filings tab.

Elevance Health quarterly results
PeriodRevenueGross profitOperating incomeNet incomeDiluted EPSGross marginOperating margin
Q3 FY2026 (ended Sep 30, 2026)$51.43B$8.01B$2.15B$1.36B$6.2715.6%4.2%
Q2 FY2026 (ended Jun 30, 2026)$50.47B$44.98B$2.06B$1.46B$6.7189.1%4.1%
Q1 FY2026 (ended Mar 31, 2026)$50.18B$9.10B$2.66B$1.76B$8.0018.1%5.3%
Q4 FY2025 (ended Dec 31, 2025)$49.75B$11.68B$581.0M$547.0M$2.4723.5%1.2%
Q3 FY2025 (ended Sep 30, 2025)$50.71B$12.57B$1.76B$1.19B$5.3224.8%3.5%
Q2 FY2025 (ended Jun 30, 2025)$49.78B$13.07B$2.63B$1.74B$7.7226.3%5.3%
Q1 FY2025 (ended Mar 31, 2025)$48.89B$13.58B$3.14B$2.18B$9.6127.8%6.4%
Q4 FY2024 (ended Dec 31, 2024)$45.44B$11.94B$946.0M$418.0M$1.8126.3%2.1%
Elevance Health quarterly cash flow
PeriodOperating cash flowCapital expendituresFree cash flowShare repurchasesDividends paid
Q3 FY2026 (ended Sep 30, 2026)$1.27B$267.0M$1.00B$330.0M$373.0M
Q2 FY2026 (ended Jun 30, 2026)$1.91B$287.0M$1.63B$234.0M$373.0M
Q1 FY2026 (ended Mar 31, 2026)$4.33B$235.0M$4.10B$1.12B$376.0M
Q4 FY2025 (ended Dec 31, 2025)$84.0M$293.0M-$209.0M$471.0M$377.0M
Q3 FY2025 (ended Sep 30, 2025)$1.14B$360.0M$775.0M$876.0M$381.0M
Q2 FY2025 (ended Jun 30, 2025)$2.05B$267.0M$1.79B$378.0M$385.0M
Q1 FY2025 (ended Mar 31, 2025)$1.02B$196.0M$821.0M$880.0M$386.0M
Q4 FY2024 (ended Dec 31, 2024)$706.0M$322.0M$384.0M$1.81B$373.0M
Elevance Health balance sheet
PeriodTotal assetsCash and equivalentsShort-term investmentsTotal debtTotal equity
Q3 FY2026 (ended Sep 30, 2026)$127.80B$10.35B$27.50B$30.76B$44.68B
Q2 FY2026 (ended Jun 30, 2026)$126.44B$10.23B$27.28B$31.04B$44.88B
Q1 FY2026 (ended Mar 31, 2026)$125.83B$9.66B$25.91B$31.84B$43.90B
Q4 FY2025 (ended Dec 31, 2025)$121.49B$9.49B$0.0M$33.23B$43.88B
Elevance Health revenue by segment
SegmentQ1 FY2026 (ended Mar 31, 2026)Q4 FY2025 (ended Dec 31, 2025)Q3 FY2025 (ended Sep 30, 2025)Q2 FY2025 (ended Jun 30, 2025)
Health Benefits$42.49B$41.84B$42.25B$41.58B
Carelon Services$17.96B$18.66B$18.32B$18.08B
Segment Eliminations-$10.96B
Elevance Health employees
YearEmployees
202597,100
2024104,200
2023104,900
2022102,300
202198,200
202083,400

Elevance Health (ELV) reported revenue of $51.43B in Q3 2026, with Health Benefits its largest revenue segment at 86%.

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites